توقعات سوق تشخيص سرطان الدماغ في أمريكا الجنوبية والوسطى حتى عام 2028 - تأثير كوفيد-19 والتحليل الإقليمي حسب نوع التشخيص (اختبار التصوير، والبزل القطني، والخزعة، والاختبار الجزيئي، وغيرها)؛ نوع السرطان (الورم العصبي الصوتي، والورم النجمي، والأورام القحفية البلعومية، والأورام العصبية العقدية، والورم الأرومي الدبقي متعدد الأشكال، والأورام السحائية، والأورام البطانية العصبية، وغيرها)؛ المستخدم النهائي (المستشفيات والعيادات المتخصصة والمراكز الجراحية المتنقلة وغيرها)

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2          Brain Cancer Diagnostics Market – By Cancer Type

1.3.3          Brain Cancer Diagnostics Market – By End User

1.3.4          South and Central America Brain Cancer Diagnostics Market – By Country

2.           South and Central America Brain Cancer Diagnostics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           South and Central America Brain Cancer Diagnostics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Brain Cancer Diagnostics Market- South and Central America PEST Analysis

4.3          Expert Opinion

5.           South and Central America Brain Cancer Diagnostics Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increase in Prevalence of Brain Cancer

5.1.2          Rise in Number of Cigarette Smokers

5.2          Market Restraints

5.2.1          High Cost of Diagnosis

5.3          Future Trends

5.3.1          Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4          Impact Analysis

6.           Brain Cancer Diagnostics Market – South and Central America Analysis

6.1          South and Central America Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7.           South and Central America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1          Overview

7.2          Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3          Imaging Tests

7.3.1          Overview

7.3.2          Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3          MRI

7.3.3.1             Overview

7.3.3.2             MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4          CT Scan

7.3.4.1             Overview

7.3.4.2             CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5          Positron emission tomography (PET)

7.3.5.1             Overview

7.3.5.2             Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Lumbar Puncture

7.4.1          Overview

7.4.2          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Biopsy

7.5.1          Overview

7.5.2          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Molecular Testing

7.6.1          Overview

7.6.2          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7          Others

7.7.1          Overview

7.7.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           South and Central America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1          Overview

8.2          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3          Astrocytomas

8.3.1          Overview

8.3.2          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Glioblastoma Multiforme

8.4.1          Overview

8.4.2          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Ependymomas

8.5.1          Overview

8.5.2          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6          Others

8.6.1          Overview

8.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Brain Cancer Diagnostics Market Analysis – By End user

9.1          Overview

9.2          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3          Hospitals

9.3.1          Overview

9.3.2          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4          Specialty Clinics

9.4.1          Overview

9.4.2          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5          Ambulatory Surgical Centers

9.5.1          Overview

9.5.2          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6          Others

9.6.1          Overview

9.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1        South and Central America: Brain Cancer Diagnostics Market

10.1.1        Overview

10.1.2        South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.2.1          Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.2          Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1           Brazil Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1.1     Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2           Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3           Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.3          Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1           Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2           Argentina Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1     Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3           Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4           Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.4          Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1           Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2           Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.3           Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4           Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.5           Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on South and Central America Brain Cancer Diagnostics Market

11.1        South and Central America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1        Overview

12.2        Growth Strategies Done by the Companies in the Market, (%)

12.1        Organic Developments

12.1.1        Overview

12.2        Inorganic Developments

12.2.1        Overview

13.        Company Profiles

13.1        THERMO FISHER SCIENTIFIC INC.

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        Siemens Healthineers AG

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        GE Healthcare

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        Biocept, Inc.

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        Koninklijke Philips N.V.

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        Canon Medical Systems

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

13.7        Hitachi, Ltd.

13.7.1        Key Facts

13.7.2        Business Description

13.7.3        Products and Services

13.7.4        Financial Overview

13.7.5        SWOT Analysis

13.7.6        Key Developments

13.8        Neusoft Medical Systems

13.8.1        Key Facts

13.8.2        Business Description

13.8.3        Products and Services

13.8.4        Financial Overview

13.8.5        SWOT Analysis

13.8.6        Key Developments

14.        Appendix

14.1        About the Insight Partners

14.2        Glossary of Terms

Table 1.              Brazil Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 2.              Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 3.              Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 4.              Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5.              Argentina Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 6.              Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 7.              Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 8.              Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 9.              Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028  (USD Million)

Table 10.            Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 11.            Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 12.            Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13.            Organic Developments in the Brain Cancer Diagnostics Market

Table 14.            Inorganic Developments in the Brain Cancer Diagnostics Market

Table 15.            Glossary of Terms, Brain Cancer Diagnostics Market

Figure 1.            Brain Cancer Diagnostics Market Segmentation

Figure 2.            South and Central America Brain Cancer Diagnostics Market Overview

Figure 3.            Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4.            Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Brain Cancer Diagnostics Market - South and Central America PEST Analysis

Figure 6.            Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7.            South and Central America Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9.            Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.          MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18.          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23.          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.          South and Central America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 28.          South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 29.          Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 30.          Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 31.          Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 32.          Impact of COVID-19 Pandemic in South and Central American Country Markets

Figure 33.          Growth Strategies Done by the Companies in the Market, (%)

1. Thermo Fisher Scientific Inc.
2. Siemens Healthineers A
3. GE Healthcare
4. Biocept, Inc.
5. Koninklijke Philips N.V
6. Canon Medical Systems
7. Hitachi, Ltd.
8. Neusoft Medical Systems

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America brain cancer diagnostics market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the South and Central America brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution